Chancellor Michael F. Collins and Mark Klempner, MD, executive vice chancellor for MassBiologics of UMass Medical School and professor of medicine, discuss the launch of Rabishield, a monoclonal antibody for rabies that was developed at MassBiologics.
RXi, founded by Craig C. Mello, PhD, Howard Hughes Medical Institute Investigator, the Blais University Chair in Molecular Medicine, distinguished professor of RNA therapeutics and chair of the company’s scientific board, closes in on commercialization of RNAi technology.
An op-ed by alum Julia Randall, MD, SOM ’15, advocates for the use of medical parole for elderly prisoners.
A study by Christian Mueller, PhD, associate professor of pediatrics, and Florie Borel, PhD, postdoctoral fellow, shows that using a technique called "nuclease-free" gene editing to correct cells with the mutation that causes a rare liver disease leads to repopulation of the diseased liver with healthy cells. Alpha-1 antitrypsin deficiency is an inherited disease that causes liver and lung damage.
A look inside Worcester’s proposal for Amazon’s east coast headquarters references UMass Medical School, the UMass Medicine Science Park and 2006 Nobel Laurette Craig C. Mello, PhD, Howard Hughes Medical Institute Investigator, the Blais University Chair in Molecular Medicine and distinguished professor of RNA therapeutics.
Using genetic studies involving canine and human genomes, Elinor Karlsson, PhD, assistant professor of molecular medicine, has identified four genetic variants linked to obsessive compulsive disorder.
Abraham L. Brass, MD, PhD, assistant professor of microbiology & physiological systems, received a grant from California-based biotechnology company Gilead Sciences Inc. for work aimed at curing HIV. Dr. Brass’s laboratory studies the interactions between viruses and hosts.
UMMS presented at the fifth annual Geek is Glam STEM event at Worcester Polytechnic Institute.
Elinor Karlsson, PhD, assistant professor of molecular medicine; Kathryn Lord, PhD, postdoctoral associate; and Diane Genereux, PhD, postdoctoral fellow, talk about their work on the behavior and genetics of wolf and dog puppies. Their research is investigating whether fear and sociability in dogs are related to the same emotions and behaviors in humans. If so, learning about dogs could provide insights into some human conditions in which social interaction is affected, like autism, Williams syndrome or schizophrenia.
A study by Carolynn M. DeBenedectis, MD, assistant professor of radiology, looks at medical school curriculum changes that may potentially increase female medical student interest in radiology.
Amy Wachholtz, PhD, assistant professor of psychiatry, comments on a study which found that patients with mental health disorders are more likely to be prescribed opioids.
Chancellor Michael F. Collins announced the Li Weibo Institute for Rare Disease Research, supported by a $10 million endowment gift from the Li Weibo Charitable Foundation in China. Terence R. Flotte, MD, the Celia and Isaac Haidak Professor of Medical Education, executive deputy chancellor, provost and dean of the School of Medicine; Katherine Luzuriaga, MD, the UMass Memorial Health Care Chair in Biomedical Research, professor of molecular medicine, pediatrics and medicine; Michael R. Green, MD, PhD, Howard Hughes Medical Institute Investigator, the Lambi and Sarah Adams Chair in Genetic Research and chair and professor of molecular, cell & cancer biology; Guangping Gao, PhD, the Penelope Booth Rockwell Professor in Biomedical Research, professor of microbiology & physiological systems, and director of the Horae Gene Therapy Center; Craig C. Mello, PhD, Howard Hughes Medical Institute Investigator, the Blais University Chair in Molecular Medicine and distinguished professor in the RNA Therapeutics Institute; and Silvia Corvera, MD, the Endowed Chair in Diabetes Research and professor of molecular medicine and cell & developmental biology, were quoted in the story.
Patrick Emery, PhD, professor of neurobiology and an expert in the genetic mechanisms that control circadian rhythms in organisms, explains the importance of the circadian rhythm discoveries made by the newly named Nobel Laureates in Physiology or Medicine, one of whom he worked with at Brandeis University.
Brian Silver, MD, vice chair and professor of neurology, explains how high blood pressure can increase the risk of stroke.
An article about the first RNAi therapy coming to clinic references RNAi’s initial discovery by Craig C. Mello, PhD, Howard Hughes Medical Institute Investigator, the Blais University Chair in Molecular Medicine and distinguished professor in the RNA Therapeutics Institute.
Bei-Hung Chang, ScD, associate professor of quantitative health sciences, is quoted in a story about guidelines dedicated to meditation by the American Heart Association. Meditation may help reduce the risk of heart disease when added to proven approaches like lifestyle changes or drugs to lower blood pressure and cholesterol.
A study by Jenifer R. Lightdale, MD, MPH, professor of pediatrics, found that capnography monitoring helps reduce respiratory compromise during procedural sedation and analgesia.
David A. Smelson, PsyD, professor of psychiatry, discusses the challenges of adapting the “MISSION” – Maintaining Independence and Sobriety through Systems Integration, Outreach and Networking – model developed by UMMS for addiction treatment to care for an entire family.
An article about Massachusetts officials seeking permission from the federal government to limit the number of medicines that would be covered by MassHealth, the state Medicaid program, references a plan to work with UMMS to develop a “rigorous review process” to set coverage for new drugs that are guaranteed clinically proven and effective.